Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi-Hsien Cheng

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
BMC Public Health|May 7, 2017
Anemia risk in relation to lead exposure in lead-related manufacturingNan-Hung Hsieh, Shun-Hui Chung, Szu-Chieh Chen, et al.
BMC Public Health|January 13, 2012
Assessing trends and predictors of tuberculosis in TaiwanChung-Min Liao, Nan-Hung Hsieh, Tang-Luen Huang, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|January 4, 2012
A probabilistic transmission and population dynamic model to assess tuberculosis infection riskChung-Min Liao, Yi-Hsien Cheng, Yi-Jun Lin, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 26, 2017
Mathematical modeling of postcoinfection with influenza A virus and <i>Streptococcus pneumoniae</i>, with implications for pneumonia and COPD-risk assessmentYi-Hsien Cheng, Shu-Han You, Yi-Jun Lin, et al.
Ecotoxicology (London, England)|May 22, 2016
Assessing exposure risks for freshwater tilapia species posed by mercury and methylmercuryYi-Hsien Cheng, Yi-Jun Lin, Shu-Han You, et al.
Archives of Toxicology|April 27, 2019
Integration of Food Animal Residue Avoidance Databank (FARAD) empirical methods for drug withdrawal interval determination with a mechanistic population-based interactive physiologically based pharmacokinetic (iPBPK) modeling platform: example for flunixin meglumine administrationMiao Li, Yi-Hsien Cheng, Jason T Chittenden, et al.
Pharmaceutical Research|May 28, 2025
Using Model Master Files to Support Oral Drug Product Development and Regulatory SubmissionsYi-Hsien Cheng, Arindom Pal, Rebecca Moody, et al.
International Journal of Nanomedicine|October 23, 2015
Physiologically based pharmacokinetic modeling of zinc oxide nanoparticles and zinc nitrate in miceWei-Yu Chen, Yi-Hsien Cheng, Nan-Hung Hsieh, et al.
Journal of Hazardous Materials|April 5, 2011
Lung cancer risk in relation to traffic-related nano/ultrafine particle-bound PAHs exposure: a preliminary probabilistic assessmentChung-Min Liao, Chia-Pin Chio, Wei-Yu Chen, et al.
Environmental Science and Pollution Research International|April 29, 2017
Mixture risk assessment due to ingestion of arsenic, copper, and zinc from milkfish farmed in contaminated coastal areasYi-Jun Lin, Min-Pei Ling, Szu-Chieh Chen, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
BMC Public Health|May 7, 2017
Anemia risk in relation to lead exposure in lead-related manufacturingNan-Hung Hsieh, Shun-Hui Chung, Szu-Chieh Chen, et al.
BMC Public Health|January 13, 2012
Assessing trends and predictors of tuberculosis in TaiwanChung-Min Liao, Nan-Hung Hsieh, Tang-Luen Huang, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|January 4, 2012
A probabilistic transmission and population dynamic model to assess tuberculosis infection riskChung-Min Liao, Yi-Hsien Cheng, Yi-Jun Lin, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 26, 2017
Mathematical modeling of postcoinfection with influenza A virus and <i>Streptococcus pneumoniae</i>, with implications for pneumonia and COPD-risk assessmentYi-Hsien Cheng, Shu-Han You, Yi-Jun Lin, et al.
Ecotoxicology (London, England)|May 22, 2016
Assessing exposure risks for freshwater tilapia species posed by mercury and methylmercuryYi-Hsien Cheng, Yi-Jun Lin, Shu-Han You, et al.
Archives of Toxicology|April 27, 2019
Integration of Food Animal Residue Avoidance Databank (FARAD) empirical methods for drug withdrawal interval determination with a mechanistic population-based interactive physiologically based pharmacokinetic (iPBPK) modeling platform: example for flunixin meglumine administrationMiao Li, Yi-Hsien Cheng, Jason T Chittenden, et al.
Pharmaceutical Research|May 28, 2025
Using Model Master Files to Support Oral Drug Product Development and Regulatory SubmissionsYi-Hsien Cheng, Arindom Pal, Rebecca Moody, et al.
International Journal of Nanomedicine|October 23, 2015
Physiologically based pharmacokinetic modeling of zinc oxide nanoparticles and zinc nitrate in miceWei-Yu Chen, Yi-Hsien Cheng, Nan-Hung Hsieh, et al.
Journal of Hazardous Materials|April 5, 2011
Lung cancer risk in relation to traffic-related nano/ultrafine particle-bound PAHs exposure: a preliminary probabilistic assessmentChung-Min Liao, Chia-Pin Chio, Wei-Yu Chen, et al.
Environmental Science and Pollution Research International|April 29, 2017
Mixture risk assessment due to ingestion of arsenic, copper, and zinc from milkfish farmed in contaminated coastal areasYi-Jun Lin, Min-Pei Ling, Szu-Chieh Chen, et al.
Pageof 4